Clinical Trial

Pomegranate Peel Extract for Primary Molar Pulpotomy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
Pomegranate peel extract has demonstrated a range of potential uses in the biomedical industry in recent years because of its numerous benefits, which include anti-inflammatory, antibacterial, anti-apoptotic, antioxidant, and cell-regeneration-promoting qualities. Therefore, the purpose of this study will be to evaluate the clinical and radiographic efficacy of Pomegranate peel extract as a pulpotomy agent in primary teeth.
Trial Details
NCT Number NCT07108738
Lead Sponsor Tanta University
Conditions Pulpitis Reversible, Pulp Exposure, Dental
Enrollment 30 participants
Start Date 2025-08
Primary Completion 2026-03 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-08-07